BUDA, ANDREA
 Distribuzione geografica
Continente #
NA - Nord America 1.423
AS - Asia 177
EU - Europa 155
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 1.757
Nazione #
US - Stati Uniti d'America 1.421
CN - Cina 97
SG - Singapore 73
IT - Italia 37
FI - Finlandia 26
DE - Germania 21
FR - Francia 21
GB - Regno Unito 15
RU - Federazione Russa 15
SE - Svezia 10
UA - Ucraina 6
IN - India 3
CA - Canada 2
JP - Giappone 2
NO - Norvegia 2
TR - Turchia 2
AU - Australia 1
EU - Europa 1
IE - Irlanda 1
LU - Lussemburgo 1
Totale 1.757
Città #
Fairfield 212
Chandler 164
Houston 131
Woodbridge 118
Ashburn 99
Cambridge 76
Ann Arbor 65
Santa Clara 62
Seattle 62
Singapore 59
Wilmington 54
Boardman 37
Princeton 30
Beijing 26
Medford 24
San Diego 22
Des Moines 21
Jacksonville 16
Helsinki 15
Roxbury 15
Padova 14
New York 8
Nanjing 7
London 6
Guangzhou 4
Hefei 4
Nanchang 4
San Jose 4
Washington 4
Zhengzhou 4
Haikou 3
Hebei 3
Jinan 3
Ogden 3
Pune 3
Redmond 3
Trapani 3
Changsha 2
Everett 2
Gaziantep 2
Kharkiv 2
Kilburn 2
Lavis 2
Preston 2
Redwood City 2
Sapporo 2
Shenyang 2
Winnipeg 2
Aprilia 1
Chicago 1
Chongqing 1
Comerio 1
Dongguan 1
Dublin 1
Falkenstein 1
Flekkeroy 1
Fuzhou 1
Genova 1
Hangzhou 1
Hanover 1
Hounslow 1
Jiaxing 1
Jinhua 1
Lappeenranta 1
Los Angeles 1
Luxembourg 1
Melbourne 1
Miami 1
Mirano 1
Munich 1
Nanping 1
Norwalk 1
Oslo 1
San Daniele del Friuli 1
Selvazzano Dentro 1
Shanghai 1
Taiyuan 1
Tampa 1
Tianjin 1
Vezzano sul Crostolo 1
Walnut 1
Wuhan 1
Totale 1.444
Nome #
Phytosome complex of curcumin as complementary therapy of advanced pancreatic cancer improves safety and efficacy of gemcitabine: Results of a prospective phase II trial 163
MiR-155 modulates the inflammatory phenotype of intestinal myofibroblasts by targeting SOCS1 in ulcerative colitis 136
Detection of a fluorescent-labeled avidin-nucleic acid nanoassembly by confocal laser endomicroscopy in the microvasculature of chronically inflamed intestinal mucosa 132
TAK1 is a key modulator of the profibrogenic phenotype of human ileal myofibroblasts in Crohn’s disease 110
Increased risk of NASH in patients carrying the C(-159)T polymorphism in the CD14 gene promoter region 109
Microbiota changes induced by microencapsulated sodium butyrate in patients with inflammatory bowel disease 92
Semiautomatic evaluation of crypt architecture and vessel morphology in confocal microendoscopy: Application to ulcerative colitis 80
Intestinal Surgery for Crohn's Disease: Predictors of Recovery, Complications and Health Related Quality of Life 75
A propensity score-weighted comparison between adalimumab originator and its biosimilars, ABP501 and SB5, in inflammatory bowel disease: a multicenter Italian study 67
The role of wireless capsule endoscopy (WCE) in the detection of occult primary neuroendocrine tumors 61
Effects of SARS-CoV-2 emergency measures on high-risk lesions detection: a multicentre cross-sectional study 60
Expression in ileal mucosa and sub-epitelial myofibroblasts is correlated to a pro-fibrogenetic phenotype in patients with Crohn's disease 58
TAK1 Expression in Ileal Mucosa and Sub-Epithelial Myofibroblasts Is Correlated to a Pro-Fibrogenic Phenotype in Patients with Crohn's Disease 54
Dual Targeted Therapy: a possible option for the management of refractory Inflammatory Bowel Disease 52
Increased intestinal permeability in obese mice: new evidences in the pathogenesis of nonalcoholic steatohepatitis. 49
Reply to comment: Screening for active COVID-19 infection prior to biologic therapy in IBD patients: primum non nŏcēre 49
Lymphoproliferative disorders in heart transplant recipients: role of hepatitis C virus (HCV) and Epstein-Barr (EBV) infection 46
Reply to comment: Asymptomatic screening for SARS COV-2 prior to commencement of biologic therapies in patients with inflammatory bowel disease - a potentially harmful practice 45
Rapid point-of-care anti-infliximab antibodies detection in clinical practice: comparison with ELISA and potential for improving therapeutic drug monitoring in IBD patients 44
Telemedicine and Remote Screening for COVID-19 in Inflammatory Bowel Disease Patients: Results from the SoCOVID-19 Survey 38
Activities related to inflammatory bowel disease management during and after the coronavirus disease 2019 lockdown in Italy: How to maintain standards of care 36
Starting a biologic therapy in IBD patients amidst COVID-19: hold, careful monitoring or testing? 34
Eosinophilic Esophagitis and Achalasia: Are We Putting All the Pieces Together? 34
Toward a potential association between eosinophilic esophagitis and Klinefelter syndrome: a case series and review of the literature 33
Reply Letter to “Oral butyrate modulates the gut microbiota in patients with inflammatory bowel disease, most likely by reversing proinflammatory metabolic reprogramming of colonocytes” 28
Therapies for inflammatory bowel disease do not pose additional risks for adverse outcomes of SARS-CoV-2 infection: an IG-IBD study 28
Chicago classification v4.0 protocol improves specificity and accuracy of diagnosis of oesophagogastric junction outflow obstruction 20
Should Patients With Inflammatory Bowel Disease Be Tested for Active COVID-19 Before Starting a Biological Treatment? 20
Biliary Tree Diagnostics: Advances in Endoscopic Imaging andand Tissue Sampling 18
Hereditary Colorectal Cancer Syndromes and Inflammatory Bowel Diseases: an ECCO CONFER Multicenter Case Series 14
Use of biologics and small molecule drugs for the management of moderate to severe ulcerative colitis: IG-IBD clinical guidelines based on the GRADE methodology 6
Totale 1.791
Categoria #
all - tutte 9.105
article - articoli 8.796
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.901


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020140 0 0 0 0 0 12 19 24 40 18 23 4
2020/2021239 12 7 9 9 33 21 12 15 32 33 35 21
2021/2022404 21 50 32 28 42 22 16 41 26 12 41 73
2022/2023291 55 43 8 29 47 35 2 23 29 4 12 4
2023/2024176 4 30 31 17 8 23 13 2 10 4 20 14
2024/2025216 0 48 32 23 94 19 0 0 0 0 0 0
Totale 1.791